Where Will Summit Therapeutics Be in 5 Years?


Summit Therapeutics (NASDAQ: SMMT) has risen in prominence in the past two years thanks to a promising pipeline candidate, ivonescimab, a potential cancer ... Read more

Bron: Fool.com: The Motley Fool
Geplaatst: 20 Dec 2024 - 12:30